|
|
||||||||
Sansum Medical Research Foundation, Santa Barbara, California
Address reprint requests to: Lois Jovanovic, MD, FACN, Sansum Medical Research Foundation, 2219 Bath Street, Santa Barbara, CA 93105
Objective: To determine if introduction of a low carbohydrate diet might be a useful option for type 2 diabetic patients who do not achieve glucose target levels despite conventional treatment.
Methods: Subjects with type 2 diabetes, either treated with diet alone (n=9) or second generation sulfonylurea agents (n=19), which were discontinued, were placed on a diet based on ideal body weight and comprised of 25% carbohydrate. After a mean of 8 weeks, they were then switched to a caloricly equivalent diet, but composed of 55% carbohydrate.
Results: Compared to baseline diet, after 8 weeks of a 25% diet, subjects showed significantly improved glycemia as evidenced by fasting blood glucose values (p<0.005) and hemoglobin A1c levels (p<0.05). Those previously treated with oral hypoglycemic agents showed, in addition, a significant decrease in weight and diastolic blood pressure despite the discontinuation of the oral agent. When then placed on a 55% carbohydrate diet, the hemoglobin A1c rose significantly over the ensuing next 12 weeks (p<0.05).
Conclusion: A low carbohydrate, caloricly-restricted diet has beneficial short-term effects in subjects with type 2 who have failed either diet or sulfonylurea therapy and may obviate the necessity for insulin. Our study also affirms the need for reassessing the role of diet whenever type 2 diabetic patients manifests hyperglycemia, despite conventional oral treatment or diet management.
Key words: type 2 diabetes mellitus, carbohydrate, hemoglobin A1c, glycemia, diet
This article has been cited by other articles:
![]() |
N. J. Davis, N. Tomuta, C. Schechter, C. R. Isasi, C.J. Segal-Isaacson, D. Stein, J. Zonszein, and J. Wylie-Rosett Comparative Study of the Effects of a 1-Year Dietary Intervention of a Low-Carbohydrate Diet Versus a Low-Fat Diet on Weight and Glycemic Control in Type 2 Diabetes Diabetes Care, July 1, 2009; 32(7): 1147 - 1152. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Garman, S. Mulroney, M. Manigrasso, E. Flynn, and C. Maric Omega-3 fatty acid rich diet prevents diabetic renal disease Am J Physiol Renal Physiol, February 1, 2009; 296(2): F306 - F316. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Bloch Low Carbohydrate Diets, Pro: Time to Rethink Our Current Strategies Nutr Clin Pract, February 1, 2005; 20(1): 3 - 12. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S Gross, L. Li, E. S Ford, and S. Liu Increased consumption of refined carbohydrates and the epidemic of type 2 diabetes in the United States: an ecologic assessment Am. J. Clinical Nutrition, May 1, 2004; 79(5): 774 - 779. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Song, O. Kwon, S. Chen, R. Daruwala, P. Eck, J. B. Park, and M. Levine Flavonoid Inhibition of Sodium-dependent Vitamin C Transporter 1 (SVCT1) and Glucose Transporter Isoform 2 (GLUT2), Intestinal Transporters for Vitamin C and Glucose J. Biol. Chem., May 3, 2002; 277(18): 15252 - 15260. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |